Interactors | Protein name | Directionality | Classification | |
|---|---|---|---|---|
| 1 | DDC+SLC18A2-DRD1 | - DRD1_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 2 | DDC+SLC18A2-DRD2 | - DRD2_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 3 | DDC+SLC18A2-DRD4 | - DRD4_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 4 | DDC+SLC18A2-DRD5 | - DRD5_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
| 5 | EDN1-EDNRA | EDN1_HUMAN - EDNRA_HUMAN | Ligand-Receptor | Signaling by Endothelin |
| 6 | GLS2+SLC1A1-GRIN1+GRIN2A | - | Ligand-Receptor | Signaling by Glutamate |
| 7 | GLS+SLC1A1-GRIN1+GRIN2A | - | Ligand-Receptor | Signaling by Glutamate |
| 8 | OXT-OXTR | NEU1_HUMAN - OXYR_HUMAN | Ligand-Receptor | Signaling by Oxytocin |
| Name | response to amphetamine |
| ID | GO_0001975 |
| collection_id | Biological process |
| Description | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine. |
| External URL | |
| Genes |